CPhI India, organised by UBM Live, will be releasing a comprehensive India pharmaceutical market report at CPhI India 2014, to be held from December 2-4, 2014 in Mumbai. The report, conducted with the help of research partner Global Business Reports, will include thought-provoking analysis from key industry players, e.g. Cipla, Piramal, Sun, Lupin, Aurobindo and Biocon, Government bodies (IBEF/Pharmexcil) and explore new growth areas emerging across the country.
The CPhI India report will feature a robust analysis of the Indian pharma market and include significant contributions from 98 companies and all major Indian manufacturers, evaluating conditions for both foreign and domestic companies. Printed copies of the detailed report will be available at CPhI India along with a media-ready version produced and launched to media at the event, including an overview of trends contained within the full report.
CPhI India will take place at the Bombay Convention and Exhibition Centre, Mumbai (India) and is expected to be attended by nearly 30,000 industry executives from over 95 countries. CPhI will co-locate with P-MEC India, ICSE India and BioPh. A series of technical seminars will take place throughout the show, providing detailed insights into current trends, issues and developments surrounding the pharma community, alongside the CPhI Pharma Awards India.
Another initiative is CPhI Global Angels charity campaign, launched earlier at CPhI Worldwide. It is designed to call on the pharma community to lend its support to this global charity that is transforming disadvantaged communities around the world.
EP News Bureau – Mumbai